AbstractGet full access to this articleView all access options for this article.Get accessReferences1. Solaimanzadeh I . (2020). Acetazolamide, nifedipine and phosphodiesterase inhibitors: rationale for their utilization as adjunctive countermeasures in the treatment of coronavirus disease 2019 (COVID-19). Cureus, 12:e7343.2. Swenson ER , Bärtsch P . (2012). High-altitude pulmonary edema. Compr Physiol, 2:2753–2773.3. Thompson BT , Chambers RC , Liu KD . (2017). Acute respiratory distress syndrome. N Engl J Med, 377:1904–1905.
